APO Research
Talk to an analyst

APO RESEARCH · REPORT

Flowable Hemostats

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Flowable Hemostats Market Outlook and Growth Opportunities 2026

31 December 2025196 pages

Choose your research edition.

Industry ResearchFlowable Hemostats Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Flowable Hemostats Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Flowable Hemostats Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Flowable Hemostats Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Flowable Hemostats Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Flowable Hemostats market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Flowable Hemostats is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Flowable Hemostats is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Flowable Hemostats is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Flowable Hemostats market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Flowable Hemostats market include Teleflex Incorporated, Baxter International and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Flowable Hemostats market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Flowable Hemostats and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Flowable Hemostats sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Flowable Hemostats market size, projected growth trends, production technologies, key applications, and end-use industries.

Flowable Hemostats Segment by Company

Teleflex Incorporated

Baxter International

Johnson & Johnson

Flowable Hemostats Segment by Type

Porcine Gelatin

Bovine Gelatin

Flowable Hemostats Segment by Application

Orthopedic Surgery

General Surgery

Neuro and Spine Surgery

Cardiac Surgery

Vascular Surgery

Others

Flowable Hemostats Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Flowable Hemostats status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Flowable Hemostats market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Flowable Hemostats significant trends, drivers, influence factors in global and regions.

6. To analyze Flowable Hemostats competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flowable Hemostats market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Flowable Hemostats and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flowable Hemostats.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Flowable Hemostats market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Flowable Hemostats industry.

Chapter 3: Detailed analysis of Flowable Hemostats manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Flowable Hemostats in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Flowable Hemostats in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Flowable Hemostats Industry Trends Table 2. Flowable Hemostats Industry Drivers Table 3. Flowable Hemostats Industry Opportunities and Challenges Table 4. Flowable Hemostats Industry Restraints Table 5. Global Flowable Hemostats Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Flowable Hemostats Revenue Share by Company (2021-2026) Table 7. Global Flowable Hemostats Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Flowable Hemostats Sales Volume Share by Company (2021-2026) Table 9. Global Flowable Hemostats Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Flowable Hemostats Company Ranking, (2024-2026) & (USD Million) Table 11. Global Flowable Hemostats Key Company Manufacturing Base & Headquarters Table 12. Global Flowable Hemostats Company, Product Type & Application Table 13. Global Flowable Hemostats Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Flowable Hemostats by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Porcine Gelatin Table 18. Significant Companies of Bovine Gelatin Table 19. Global Flowable Hemostats Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Flowable Hemostats Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Flowable Hemostats Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Flowable Hemostats Sales Volume Share by Type (2021-2026) Table 23. Global Flowable Hemostats Sales Volume Share by Type (2027-2032) Table 24. Global Flowable Hemostats Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Flowable Hemostats Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Flowable Hemostats Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Flowable Hemostats Sales Value Share by Type (2021-2026) Table 28. Global Flowable Hemostats Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Orthopedic Surgery Table 30. Significant Companies of General Surgery Table 31. Significant Companies of Neuro and Spine Surgery Table 32. Significant Companies of Cardiac Surgery Table 33. Significant Companies of Vascular Surgery Table 34. Significant Companies of Others Table 35. Global Flowable Hemostats Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Flowable Hemostats Sales Volume by Application (2021-2026) & (K Units) Table 37. Global Flowable Hemostats Sales Volume by Application (2027-2032) & (K Units) Table 38. Global Flowable Hemostats Sales Volume Share by Application (2021-2026) Table 39. Global Flowable Hemostats Sales Volume Share by Application (2027-2032) Table 40. Global Flowable Hemostats Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Flowable Hemostats Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Flowable Hemostats Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Flowable Hemostats Sales Value Share by Application (2021-2026) Table 44. Global Flowable Hemostats Sales Value Share by Application (2027-2032) Table 45. Global Flowable Hemostats Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Flowable Hemostats Sales by Region (2021-2026) & (K Units) Table 47. Global Flowable Hemostats Sales Market Share by Region (2021-2026) Table 48. Global Flowable Hemostats Sales by Region (2027-2032) & (K Units) Table 49. Global Flowable Hemostats Sales Market Share by Region (2027-2032) Table 50. Global Flowable Hemostats Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Flowable Hemostats Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Flowable Hemostats Sales Value Share by Region (2021-2026) Table 53. Global Flowable Hemostats Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Flowable Hemostats Sales Value Share by Region (2027-2032) Table 55. Global Flowable Hemostats Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Flowable Hemostats Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Flowable Hemostats Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global Flowable Hemostats Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Flowable Hemostats Sales by Country (2021-2026) & (K Units) Table 60. Global Flowable Hemostats Sales Market Share by Country (2021-2026) Table 61. Global Flowable Hemostats Sales by Country (2027-2032) & (K Units) Table 62. Global Flowable Hemostats Sales Market Share by Country (2027-2032) Table 63. Global Flowable Hemostats Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Flowable Hemostats Sales Value Market Share by Country (2021-2026) Table 65. Global Flowable Hemostats Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Flowable Hemostats Sales Value Market Share by Country (2027-2032) Table 67. Teleflex Incorporated Company Information Table 68. Teleflex Incorporated Business Overview Table 69. Teleflex Incorporated Flowable Hemostats Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Teleflex Incorporated Flowable Hemostats Product Portfolio Table 71. Teleflex Incorporated Recent Development Table 72. Baxter International Company Information Table 73. Baxter International Business Overview Table 74. Baxter International Flowable Hemostats Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Baxter International Flowable Hemostats Product Portfolio Table 76. Baxter International Recent Development Table 77. Johnson & Johnson Company Information Table 78. Johnson & Johnson Business Overview Table 79. Johnson & Johnson Flowable Hemostats Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Johnson & Johnson Flowable Hemostats Product Portfolio Table 81. Johnson & Johnson Recent Development Table 82. Key Raw Materials Table 83. Raw Materials Key Suppliers Table 84. Flowable Hemostats Distributors List Table 85. Flowable Hemostats Customers List Table 86. Research Programs/Design for This Report Table 87. Authors List of This Report Table 88. Secondary Sources Table 89. Primary Sources List of Figures Figure 1. Flowable Hemostats Product Image Figure 2. Global Flowable Hemostats Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Flowable Hemostats Sales Value (2021-2032) & (US$ Million) Figure 4. Global Flowable Hemostats Sales (2021-2032) & (K Units) Figure 5. Global Flowable Hemostats Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Flowable Hemostats Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Porcine Gelatin Image Figure 10. Bovine Gelatin Image Figure 11. Global Flowable Hemostats Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Flowable Hemostats Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Flowable Hemostats Sales Volume Share by Type (2021-2032) Figure 14. Global Flowable Hemostats Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Flowable Hemostats Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Flowable Hemostats Sales Value Share by Type (2021-2032) Figure 17. Orthopedic Surgery Image Figure 18. General Surgery Image Figure 19. Neuro and Spine Surgery Image Figure 20. Cardiac Surgery Image Figure 21. Vascular Surgery Image Figure 22. Others Image Figure 23. Global Flowable Hemostats Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Flowable Hemostats Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Flowable Hemostats Sales Volume Share by Application (2021-2032) Figure 26. Global Flowable Hemostats Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Flowable Hemostats Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Flowable Hemostats Sales Value Share by Application (2021-2032) Figure 29. Global Flowable Hemostats Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global Flowable Hemostats Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Flowable Hemostats Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Flowable Hemostats Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Flowable Hemostats Sales Value (2021-2032) & (US$ Million) Figure 34. North America Flowable Hemostats Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Flowable Hemostats Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Flowable Hemostats Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Flowable Hemostats Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Flowable Hemostats Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Flowable Hemostats Sales Value (2021-2032) & (US$ Million) Figure 40. South America Flowable Hemostats Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Flowable Hemostats Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Flowable Hemostats Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Flowable Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Flowable Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Flowable Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Flowable Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Flowable Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Flowable Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Flowable Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Flowable Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Flowable Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Flowable Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Flowable Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Flowable Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Flowable Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Flowable Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Flowable Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Flowable Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Flowable Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Flowable Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Flowable Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Flowable Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Flowable Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Flowable Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Flowable Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Flowable Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Flowable Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Flowable Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Flowable Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Flowable Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Flowable Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Flowable Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Flowable Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Flowable Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Flowable Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Flowable Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Flowable Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Flowable Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Flowable Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Flowable Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Flowable Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Flowable Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Flowable Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Flowable Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Flowable Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Flowable Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Flowable Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Flowable Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Flowable Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Flowable Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Flowable Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Flowable Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Flowable Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Flowable Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Flowable Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Flowable Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Flowable Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Flowable Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Flowable Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Flowable Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Flowable Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Flowable Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Flowable Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Flowable Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Flowable Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Flowable Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Flowable Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Flowable Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Flowable Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Flowable Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Flowable Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Flowable Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Flowable Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Flowable Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Flowable Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Flowable Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Flowable Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Flowable Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Flowable Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Flowable Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Flowable Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Flowable Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Flowable Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Flowable Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Flowable Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Flowable Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Flowable Hemostats Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Flowable Hemostats Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Porcine Gelatin
  • Bovine Gelatin
Applications
  • Orthopedic Surgery
  • General Surgery
  • Neuro and Spine Surgery
  • Cardiac Surgery
  • Vascular Surgery
  • Others
Companies covered
  • Teleflex Incorporated
  • Baxter International
  • Johnson & Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Flowable Hemostats Sales Value (2021-2032)
  4. 1.2.2 Global Flowable Hemostats Sales Volume (2021-2032)
  5. 1.2.3 Global Flowable Hemostats Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Flowable Hemostats Market Dynamics
  1. 2.1 Flowable Hemostats Industry Trends
  2. 2.2 Flowable Hemostats Industry Drivers
  3. 2.3 Flowable Hemostats Industry Opportunities and Challenges
  4. 2.4 Flowable Hemostats Industry Restraints
3 Flowable Hemostats Market by Company
  1. 3.1 Global Flowable Hemostats Company Revenue Ranking in 2025
  2. 3.2 Global Flowable Hemostats Revenue by Company (2021-2026)
  3. 3.3 Global Flowable Hemostats Sales Volume by Company (2021-2026)
  4. 3.4 Global Flowable Hemostats Average Price by Company (2021-2026)
  5. 3.5 Global Flowable Hemostats Company Ranking (2024-2026)
  6. 3.6 Global Flowable Hemostats Company Manufacturing Base and Headquarters
  7. 3.7 Global Flowable Hemostats Company Product Type and Application
  8. 3.8 Global Flowable Hemostats Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Flowable Hemostats Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Flowable Hemostats Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Flowable Hemostats Market by Type
  1. 4.1 Flowable Hemostats Type Introduction
  2. 4.1.1 Porcine Gelatin
  3. 4.1.2 Bovine Gelatin
  4. 4.2 Global Flowable Hemostats Sales Volume by Type
  5. 4.2.1 Global Flowable Hemostats Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Flowable Hemostats Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Flowable Hemostats Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Flowable Hemostats Sales Value by Type
  9. 4.3.1 Global Flowable Hemostats Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Flowable Hemostats Sales Value by Type (2021-2032)
  11. 4.3.3 Global Flowable Hemostats Sales Value Share by Type (2021-2032)
5 Flowable Hemostats Market by Application
  1. 5.1 Flowable Hemostats Application Introduction
  2. 5.1.1 Orthopedic Surgery
  3. 5.1.2 General Surgery
  4. 5.1.3 Neuro and Spine Surgery
  5. 5.1.4 Cardiac Surgery
  6. 5.1.5 Vascular Surgery
  7. 5.1.6 Others
  8. 5.2 Global Flowable Hemostats Sales Volume by Application
  9. 5.2.1 Global Flowable Hemostats Sales Volume by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Flowable Hemostats Sales Volume by Application (2021-2032)
  11. 5.2.3 Global Flowable Hemostats Sales Volume Share by Application (2021-2032)
  12. 5.3 Global Flowable Hemostats Sales Value by Application
  13. 5.3.1 Global Flowable Hemostats Sales Value by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Flowable Hemostats Sales Value by Application (2021-2032)
  15. 5.3.3 Global Flowable Hemostats Sales Value Share by Application (2021-2032)
6 Flowable Hemostats Regional Sales and Value Analysis
  1. 6.1 Global Flowable Hemostats Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Flowable Hemostats Sales by Region (2021-2032)
  3. 6.2.1 Global Flowable Hemostats Sales by Region: 2021-2026
  4. 6.2.2 Global Flowable Hemostats Sales by Region (2027-2032)
  5. 6.3 Global Flowable Hemostats Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Flowable Hemostats Sales Value by Region (2021-2032)
  7. 6.4.1 Global Flowable Hemostats Sales Value by Region: 2021-2026
  8. 6.4.2 Global Flowable Hemostats Sales Value by Region (2027-2032)
  9. 6.5 Global Flowable Hemostats Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Flowable Hemostats Sales Value (2021-2032)
  12. 6.6.2 North America Flowable Hemostats Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Flowable Hemostats Sales Value (2021-2032)
  15. 6.7.2 Europe Flowable Hemostats Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Flowable Hemostats Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Flowable Hemostats Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Flowable Hemostats Sales Value (2021-2032)
  21. 6.9.2 South America Flowable Hemostats Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Flowable Hemostats Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Flowable Hemostats Sales Value Share by Country, 2025 VS 2032
7 Flowable Hemostats Country-level Sales and Value Analysis
  1. 7.1 Global Flowable Hemostats Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Flowable Hemostats Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Flowable Hemostats Sales by Country (2021-2032)
  4. 7.3.1 Global Flowable Hemostats Sales by Country (2021-2026)
  5. 7.3.2 Global Flowable Hemostats Sales by Country (2027-2032)
  6. 7.4 Global Flowable Hemostats Sales Value by Country (2021-2032)
  7. 7.4.1 Global Flowable Hemostats Sales Value by Country (2021-2026)
  8. 7.4.2 Global Flowable Hemostats Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Flowable Hemostats Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Flowable Hemostats Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Flowable Hemostats Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Flowable Hemostats Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Flowable Hemostats Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Flowable Hemostats Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Flowable Hemostats Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Flowable Hemostats Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Flowable Hemostats Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Flowable Hemostats Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Flowable Hemostats Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Flowable Hemostats Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Flowable Hemostats Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Flowable Hemostats Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Flowable Hemostats Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Flowable Hemostats Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Flowable Hemostats Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Flowable Hemostats Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Flowable Hemostats Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Flowable Hemostats Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Flowable Hemostats Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Flowable Hemostats Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Flowable Hemostats Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Flowable Hemostats Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Flowable Hemostats Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Flowable Hemostats Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Flowable Hemostats Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Flowable Hemostats Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Flowable Hemostats Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Flowable Hemostats Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Flowable Hemostats Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Flowable Hemostats Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Flowable Hemostats Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Flowable Hemostats Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Flowable Hemostats Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Flowable Hemostats Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Flowable Hemostats Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Flowable Hemostats Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Flowable Hemostats Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Flowable Hemostats Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Flowable Hemostats Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Flowable Hemostats Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Flowable Hemostats Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Flowable Hemostats Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Flowable Hemostats Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Flowable Hemostats Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Flowable Hemostats Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Flowable Hemostats Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Flowable Hemostats Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Flowable Hemostats Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Flowable Hemostats Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Flowable Hemostats Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Flowable Hemostats Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Flowable Hemostats Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Flowable Hemostats Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Flowable Hemostats Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Flowable Hemostats Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Flowable Hemostats Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Flowable Hemostats Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Flowable Hemostats Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Flowable Hemostats Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Flowable Hemostats Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Flowable Hemostats Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Flowable Hemostats Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Flowable Hemostats Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Flowable Hemostats Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Flowable Hemostats Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Flowable Hemostats Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Flowable Hemostats Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Flowable Hemostats Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Flowable Hemostats Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Flowable Hemostats Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Flowable Hemostats Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Flowable Hemostats Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Flowable Hemostats Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Flowable Hemostats Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Flowable Hemostats Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Flowable Hemostats Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Flowable Hemostats Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Flowable Hemostats Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Flowable Hemostats Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Flowable Hemostats Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Flowable Hemostats Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Flowable Hemostats Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teleflex Incorporated
  2. 8.1.1 Teleflex Incorporated Company Information
  3. 8.1.2 Teleflex Incorporated Business Overview
  4. 8.1.3 Teleflex Incorporated Flowable Hemostats Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teleflex Incorporated Flowable Hemostats Product Portfolio
  6. 8.1.5 Teleflex Incorporated Recent Developments
  7. 8.2 Baxter International
  8. 8.2.1 Baxter International Company Information
  9. 8.2.2 Baxter International Business Overview
  10. 8.2.3 Baxter International Flowable Hemostats Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Baxter International Flowable Hemostats Product Portfolio
  12. 8.2.5 Baxter International Recent Developments
  13. 8.3 Johnson & Johnson
  14. 8.3.1 Johnson & Johnson Company Information
  15. 8.3.2 Johnson & Johnson Business Overview
  16. 8.3.3 Johnson & Johnson Flowable Hemostats Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Johnson & Johnson Flowable Hemostats Product Portfolio
  18. 8.3.5 Johnson & Johnson Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Flowable Hemostats Value Chain Analysis
  2. 9.1.1 Flowable Hemostats Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Flowable Hemostats Sales Mode & Process
  6. 9.2 Flowable Hemostats Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Flowable Hemostats Distributors
  9. 9.2.3 Flowable Hemostats Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst